These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

713 related items for PubMed ID: 16635513

  • 1. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ, Wang ZP, Rodriguez R, Fu JS, Lu JZ, Ma BL.
    Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
    [Abstract] [Full Text] [Related]

  • 2. Dendritic cell transfected with secondary lymphoid-tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cell S in vitro.
    Li YG, Wang ZP, Tian JQ, Tian BQ, Rodrigues R, Shang PF, Zhang T.
    Cancer Invest; 2009 Nov; 27(9):909-17. PubMed ID: 19832038
    [Abstract] [Full Text] [Related]

  • 3. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
    Morita T, Salmeron MA, Hayakawa K, Swanson DA, von Eschenbach AC, Itoh K.
    Reg Immunol; 1992 Nov; 4(4):225-35. PubMed ID: 1476875
    [Abstract] [Full Text] [Related]

  • 4. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H.
    J Immunol; 1999 Aug 15; 163(4):1906-13. PubMed ID: 10438925
    [Abstract] [Full Text] [Related]

  • 5. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S, Koike N, Adachi S.
    J Cancer Res Clin Oncol; 2002 Feb 15; 128(2):73-9. PubMed ID: 11862476
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors.
    VanOosten RL, Earel JK, Griffith TS.
    Cancer Gene Ther; 2006 Jun 15; 13(6):628-32. PubMed ID: 16456549
    [Abstract] [Full Text] [Related]

  • 7. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
    Griffith TS, Fialkov JM, Scott DL, Azuhata T, Williams RD, Wall NR, Altieri DC, Sandler AD.
    Cancer Res; 2002 Jun 01; 62(11):3093-9. PubMed ID: 12036919
    [Abstract] [Full Text] [Related]

  • 8. Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model.
    Lefor AT, Fabian DF.
    J Surg Res; 1998 Feb 15; 75(1):49-53. PubMed ID: 9614856
    [Abstract] [Full Text] [Related]

  • 9. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells.
    Thomas WD, Hersey P.
    J Immunol; 1998 Sep 01; 161(5):2195-200. PubMed ID: 9725211
    [Abstract] [Full Text] [Related]

  • 10. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
    Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, Canioni D, Berrebi D, Brousse N, Desreumaux P, Schmitz J, Lentze MJ, Goulet O, Cerf-Bensussan N, Ruemmele FM.
    Gastroenterology; 2006 Jun 01; 130(7):1962-74. PubMed ID: 16762619
    [Abstract] [Full Text] [Related]

  • 11. [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].
    Zhang YX, Wang XY, Liu JB, Zhang SQ, Chen YR.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):973-6. PubMed ID: 18756970
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM, Tsai WS, Ziauddin MF, Zuo J, Cole GW, Maxhimer JB, Fang B, Schrump DS, Nguyen DM.
    J Thorac Cardiovasc Surg; 2004 Dec 08; 128(6):883-91. PubMed ID: 15573073
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.
    Mulders P, Tso CL, Pang S, Kaboo R, McBride WH, Hinkel A, Gitlitz B, Dannull J, Figlin R, Belldegrun A.
    J Immunother; 1998 May 08; 21(3):170-80. PubMed ID: 9610908
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B.
    Cancer Res; 2001 Apr 15; 61(8):3330-8. PubMed ID: 11309289
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M.
    Clin Cancer Res; 2004 Dec 01; 10(23):7884-95. PubMed ID: 15585621
    [Abstract] [Full Text] [Related]

  • 17. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, Yagita H.
    J Immunol; 1999 Mar 01; 162(5):2639-47. PubMed ID: 10072506
    [Abstract] [Full Text] [Related]

  • 18. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
    Shiraki K, Yamanaka T, Inoue H, Kawakita T, Enokimura N, Okano H, Sugimoto K, Murata K, Nakano T.
    Int J Oncol; 2005 May 01; 26(5):1273-81. PubMed ID: 15809718
    [Abstract] [Full Text] [Related]

  • 19. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
    Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Hum Pathol; 2005 Oct 01; 36(10):1066-73. PubMed ID: 16226105
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH, Rayman P, Alexander J, Edinger M, Tubbs RR, Connelly R, Pontes E, Bukowski R.
    Cancer Res; 1990 Apr 15; 50(8):2363-70. PubMed ID: 2107973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.